Thursday, July 01, 2021 7:30:07 AM
July 01 2021 - 06:08AM
This prospectus relates to the offer and sale of up to 18,012,845 shares of our common stock, $0.0001 par value per share (“Common Stock”), by Tumim Stone Capital, LLC (“Tumim” or the “Selling Stockholder”).
The shares of common stock being offered by the Selling Stockholder have been and may be issued pursuant to the purchase agreement dated June 11, 2021 that we entered into with Tumim (the “Purchase Agreement”). We are not selling any securities under this prospectus and will not receive any of the proceeds from the sale of our Common Stock by the Selling Stockholder. However, we may receive up to $300.0 million in aggregate gross proceeds from sales of our Common Stock to Tumim that we may make under the Purchase Agreement, from time to time after the date of this prospectus. On June 11, 2021, we issued 155,703 shares of our Common Stock (the “Commitment Shares”) to Tumim as consideration for its irrevocable commitment to purchase shares of our Common Stock under the Purchase Agreement. See the sections titled “The Tumim Transaction” for a description of the transaction contemplated by the Purchase Agreement and “Selling Stockholder” for additional information regarding Tumim.
The Selling Stockholder may sell the shares of Common Stock included in this prospectus in a number of different ways and at varying prices. We provide more information about how the Selling Stockholder may sell the shares in the section entitled “Plan of Distribution.” The Selling Stockholder is an “underwriter” within the meaning of Section 2(a)(11) of the Securities Act of 1933, as amended (the “Securities Act”).
The Selling Stockholder will pay all brokerage fees and commissions and similar expenses in connection with the offer and sale of the shares by the Selling Stockholder pursuant to this prospectus. We will pay the expenses (except brokerage fees and commissions and similar expenses) incurred in registering under the Securities Act the offer and sale of the shares included in this prospectus by the Selling Stockholder, including legal and accounting fees. See “Plan of Distribution.”
Our Common Stock is listed on the Nasdaq Global Select Market under the symbol “NKLA”. On June 30, 2021, the closing price of our Common Stock was $18.06.
Recent NKLA News
- NIKOLA CHAIRMAN ADDRESSES STOCKHOLDER QUESTIONS ON REVERSE SPLIT PROPOSAL IN DEFINITIVE PROXY STATEMENT • PR Newswire (US) • 04/30/2024 12:05:00 PM
- M&M Residual and Trevor R. Milton Announce Concerns Related to Potential Fraud and Misconduct at Nikola Overseen by Steve Girsky, Britton Worthen and the Board of Directors • Business Wire • 04/11/2024 03:30:00 PM
- Apple Terminates 614 Employees, Disney Unveils June Crackdown on Password Sharing, and More Updates • IH Market News • 04/05/2024 11:38:57 AM
- NIKOLA CORPORATION ANNOUNCES DATE FOR FIRST QUARTER 2024 RESULTS AND WEBCAST AND Q&A PLATFORM FOR SHAREHOLDERS • PR Newswire (US) • 04/04/2024 08:05:00 PM
- NIKOLA PRODUCES 43, WHOLESALES 40 HYDROGEN FUEL CELL ELECTRIC TRUCKS FOR U.S. CUSTOMERS IN Q1 2024 • PR Newswire (US) • 04/04/2024 12:05:00 PM
- NIKOLA CELEBRATES GRAND OPENING OF FIRST HYLA REFUELING STATION IN SOUTHERN CALIFORNIA • PR Newswire (US) • 03/21/2024 10:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/07/2024 11:59:55 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/07/2024 11:59:37 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/07/2024 11:59:30 PM
- IMC UNVEILS DESIGN OF ITS 50 NIKOLA HYDROGEN FUEL CELL ELECTRIC TRUCKS AT GRAND OPENING OF SUSTAINABLE FACILITY • PR Newswire (US) • 03/07/2024 09:05:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/07/2024 07:43:37 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/07/2024 07:42:49 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/05/2024 08:40:53 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/05/2024 08:30:54 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/05/2024 08:25:51 PM
- AMD Hits Regulatory Roadblock, GitLab’s Stock Tumbles on Disappointing Earnings, and Latest News • IH Market News • 03/05/2024 11:05:08 AM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 03/04/2024 01:21:00 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 03/04/2024 01:15:14 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/04/2024 01:08:35 PM
- THOMAS B. OKRAY NAMED CHIEF FINANCIAL OFFICER OF NIKOLA CORPORATION • PR Newswire (US) • 03/04/2024 01:05:00 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 03/01/2024 09:48:16 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 03/01/2024 09:48:09 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 03/01/2024 09:37:37 PM
- Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend] • Edgar (US Regulatory) • 03/01/2024 09:20:39 PM
- Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend] • Edgar (US Regulatory) • 03/01/2024 09:11:02 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM